Status:
NOT_YET_RECRUITING
Tailored Patient Navigation to Improve the Uptake of Lung Cancer Screening in Tribal Communities in Western Washington State, SACRED LUNGS Trial
Lead Sponsor:
Fred Hutchinson Cancer Center
Collaborating Sponsors:
National Institute on Minority Health and Health Disparities (NIMHD)
Conditions:
Lung Carcinoma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This clinical trial studies whether tailored patient navigation (PN) works to improve the uptake of lung cancer screening (LCS) in tribal communities in western Washington state. Lung cancer is the le...
Detailed Description
OUTLINE: Participants are randomized to 1 of 2 arms. ARM 1: Participants receive tailored PN activities in support of the uptake and follow-up of LCS for 21 months. Participants also receive an educa...
Eligibility Criteria
Inclusion
- AIM 1 RANDOMIZED CONTROLLED TRIAL: Between ages 50-77
- AIM 1 RANDOMIZED CONTROLLED TRIAL: Self-reported 20-pack year smoking history
- AIM 1 RANDOMIZED CONTROLLED TRIAL: Ongoing commercial tobacco use within the past 15 years
- AIM 1 RANDOMIZED CONTROLLED TRIAL: Seen by a PCP at a participating clinic (South Puget Intertribal Planning Agency \[SPIPA\] or Muckleshoot) within the past three years
- Potential participants who want to establish care at an eligible clinic will be connected to a PCP
- AIM 2 CLINICAL STAFF SURVEYS AND SEMI-STRUCTURED INTERVIEWS: At least 18 years of age
- AIM 2 CLINICAL STAFF SURVEYS AND SEMI-STRUCTURED INTERVIEWS: Affiliation with Muckleshoot or SPIPA (one of the 6 community partnering clinics) as a provider, or supportive staff member
- AIM 2 PATIENT SURVEYS AND SEMI-STRUCTURED INTERVIEWS: Patient participated in the aim 1 trial
- AIM 3 CLINICAL STAFF SURVEYS AND SEMI-STRUCTURED INTERVIEWS: At least 18 years of age
- AIM 3 CLINICAL STAFF SURVEYS AND SEMI-STRUCTURED INTERVIEWS: Affiliation with Muckleshoot or SPIPA (one of the 6 community partnering clinics) as a provider, or supportive staff member
- AIM 3 PATIENT SURVEYS AND SEMI-STRUCTURED INTERVIEWS: Patient participated in the aim 1 trial
Exclusion
- AIM 1 RANDOMIZED CONTROLLED TRIAL: Has had a documented chest CT within the past one year
- AIM 1 RANDOMIZED CONTROLLED TRIAL: Personal history of lung cancer or symptoms associated with lung cancer
Key Trial Info
Start Date :
March 1 2026
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 30 2029
Estimated Enrollment :
237 Patients enrolled
Trial Details
Trial ID
NCT07176000
Start Date
March 1 2026
End Date
April 30 2029
Last Update
December 29 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Muckleshoot Tribal Clinic
Auburn, Washington, United States, 98092
2
South Puget Intertribal Planning Agency (SPIPA)
Shelton, Washington, United States, 98584